JP2004534813A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534813A5
JP2004534813A5 JP2003506887A JP2003506887A JP2004534813A5 JP 2004534813 A5 JP2004534813 A5 JP 2004534813A5 JP 2003506887 A JP2003506887 A JP 2003506887A JP 2003506887 A JP2003506887 A JP 2003506887A JP 2004534813 A5 JP2004534813 A5 JP 2004534813A5
Authority
JP
Japan
Prior art keywords
cellobiose
carrier
pharmaceutical composition
powder
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003506887A
Other languages
English (en)
Japanese (ja)
Other versions
JP4348179B2 (ja
JP2004534813A (ja
Filing date
Publication date
Priority claimed from US09/885,349 external-priority patent/US6482429B1/en
Application filed filed Critical
Publication of JP2004534813A publication Critical patent/JP2004534813A/ja
Publication of JP2004534813A5 publication Critical patent/JP2004534813A5/ja
Application granted granted Critical
Publication of JP4348179B2 publication Critical patent/JP4348179B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003506887A 2001-06-20 2002-06-11 安定な粉末吸入投与組成物 Expired - Lifetime JP4348179B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/885,349 US6482429B1 (en) 2001-06-20 2001-06-20 Stable powder inhalation dosage formulation
PCT/US2002/018406 WO2003000240A2 (en) 2001-06-20 2002-06-11 Stable powder inhalation dosage formulation

Publications (3)

Publication Number Publication Date
JP2004534813A JP2004534813A (ja) 2004-11-18
JP2004534813A5 true JP2004534813A5 (enExample) 2006-01-05
JP4348179B2 JP4348179B2 (ja) 2009-10-21

Family

ID=25386707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003506887A Expired - Lifetime JP4348179B2 (ja) 2001-06-20 2002-06-11 安定な粉末吸入投与組成物

Country Status (9)

Country Link
US (1) US6482429B1 (enExample)
EP (1) EP1401409B1 (enExample)
JP (1) JP4348179B2 (enExample)
AT (1) ATE459346T1 (enExample)
CA (1) CA2446221C (enExample)
DE (1) DE60235544D1 (enExample)
ES (1) ES2339751T3 (enExample)
MX (1) MXPA03011517A (enExample)
WO (1) WO2003000240A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408499D0 (en) 1994-04-28 1994-06-22 Edwin Shirley Trucking Limited A releasable joint for joining two construction elements of a transportable stage assembly
AP1712A (en) * 2000-10-12 2007-01-24 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
CA2546454A1 (en) * 2003-11-18 2005-06-02 Yansong Shan Healthy pleasurable inhalation device
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
WO2007037249A1 (ja) * 2005-09-27 2007-04-05 Asahi Kasei Chemicals Corporation セロオリゴ糖含有組成物
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions

Similar Documents

Publication Publication Date Title
Newman Dry powder inhalers for optimal drug delivery
JP2007106777A5 (enExample)
CA2226934C (en) Ipratropium bromide enantiomer with a prolonged duration of action
JP3567329B2 (ja) 吸入散剤及びその製造方法
CA2369726A1 (en) Powder inhaler for combined medicament
WO2007123955A3 (en) Stable hydroalcoholic oral spray formulations and methods
JP2013544781A5 (enExample)
CA2395653A1 (en) New inhalable powder containing tiotropium
JP2011520911A5 (enExample)
JP2013534227A5 (enExample)
JP2002538110A5 (enExample)
CA2369722A1 (en) Powder inhaler for combined medicament
JP2014509313A5 (enExample)
WO2001095874A2 (en) Highly efficient delivery of a large therapeutic mass aerosol
JP2020527377A5 (enExample)
WO2005079755A3 (en) Interleukin-13 antagonist powders, spray-dried particles, and methods
RU2007124795A (ru) Медицинский продукт, содержащий лекарственное средство на основе глюкагоноподобного пептида, предназначенное для легочной ингаляции
RU2006112589A (ru) Фармацевтические композиции для лечения преждевременной эякуляции при помощи легочной ингаляции
CA2405767A1 (en) Pharmaceutical formulations for dry powder inhalers
BR0317443A (pt) Medicamento pulverulento para inalação contendo um sal de tiotrópio e xinafoato de salmeterol
WO2006008517A3 (en) Use of dry powder compositions for pulmonary delivery
JP2002529396A5 (enExample)
NO984999D0 (no) Metoder for inhalasjon av t°rt pulver
JP2011157405A5 (enExample)
JP2016515576A5 (enExample)